Life sciences-focused private equity fund EILSF (Evolvence India Life Sciences Fund), which has just struck a deal with buyout giant KKR & Co to sell its stake in Gland Pharma Ltd, has hit first close of its follow-on fund and is now looking to complete the fundraising process by the ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.